Your browser doesn't support javascript.
loading
Healthy and diseased in vitro models of vascular systems.
Hosseini, Vahid; Mallone, Anna; Nasrollahi, Fatemeh; Ostrovidov, Serge; Nasiri, Rohollah; Mahmoodi, Mahboobeh; Haghniaz, Reihaneh; Baidya, Avijit; Salek, M Mehdi; Darabi, Mohammad Ali; Orive, Gorka; Shamloo, Amir; Dokmeci, Mehmet R; Ahadian, Samad; Khademhosseini, Ali.
Affiliation
  • Hosseini V; Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024,
  • Mallone A; Institute of Regenerative Medicine, University of Zurich, Zurich CH-8952, Switzerland.
  • Nasrollahi F; Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024,
  • Ostrovidov S; Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and Department of Radiological Sciences, University of California-Los Angeles, CA 90095, USA.
  • Nasiri R; Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Department of Mechanical Engineering, Sharif University of Technology
  • Mahmoodi M; Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Department of Biomedical Engineering, Yazd Branch, Islamic Azad Unive
  • Haghniaz R; Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024,
  • Baidya A; Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA.
  • Salek MM; School of Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA.
  • Darabi MA; Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024,
  • Orive G; NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, Vitoria-Gasteiz 01006, Spain and Biomedical Research Networking Centre in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz 01007, Spain.
  • Shamloo A; Department of Mechanical Engineering, Sharif University of Technology, Tehran 1136511155, Iran.
  • Dokmeci MR; Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024,
  • Ahadian S; Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024,
  • Khademhosseini A; Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024,
Lab Chip ; 21(4): 641-659, 2021 02 23.
Article in En | MEDLINE | ID: mdl-33507199
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atherosclerosis / Hemodynamics Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Lab Chip Journal subject: BIOTECNOLOGIA / QUIMICA Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atherosclerosis / Hemodynamics Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Lab Chip Journal subject: BIOTECNOLOGIA / QUIMICA Year: 2021 Type: Article